Mar 19

Panel Talk: Psychedelic Science and Mental Health

3:30pm - 5:00pm Hammond Hall | Main Lounge

About This Event

Psychedelics, such as psilocybin and MDMA, are promising treatments for mental-health disorders including addiction, depression, anxiety, and PTSD. This panel, featuring experts from medicine, neuroscience, and clinical practice, will discuss psychedelic-assisted therapy and research. Medical, scientific, and social aspects of psychedelic-assisted therapy will be addressed, as well as future prospects and challenges.

The panel will include:

  • Yvan Beaussant (MD, MSc, Harvard Medical School, Dana-Farber Cancer Institute), a hematologist, palliative care physician, and clinical investigator, with training in psychedelic research and therapy. He studies the effects and mechanisms of psilocybin- and MDMA-assisted therapy on depression, pain, and existential distress in patients with serious illness. 
  • Francis Guerriero (MA, LICSW), a therapist, trainer, supervisor, and clinical social worker in private practice. He trains and supervises local clinicians in psychedelic-assisted psychotherapy. He was a therapist on a national study of MDMA-assisted therapy for PTSD, deemed a breakthrough therapy by the FDA and currently under FDA review for approval.
  • Alexandre Lehmann (PhD, McGill University, Montreal), a cognitive neuroscientist and a psychedelic science advisor to media and nonprofits. Fascinated by the therapeutic potential of music and non-ordinary states, he has been involved in ketamine and psilocybin research.

The talk will be moderated by Associate Professor Michael Hove (Psychological Science), who studies altered states of consciousness. Sponsored by the Psychological Science Department and the School of Health and Natural Sciences.